The Prognostic Value of Neuroendocrine Differentiation in Adenocarcinoma of the Prostate in Relation to Progression of Disease After Endocrine Therapy - Concepedia

Concepedia

Publication | Closed Access

The Prognostic Value of Neuroendocrine Differentiation in Adenocarcinoma of the Prostate in Relation to Progression of Disease After Endocrine Therapy

111

Citations

19

References

1997

Year

Jose L.M. Krijnen, Jacques F. Bogdanowicz, Cees A. Seldenrijk, Paul Mulder, Theodorus van der Kwast

The Journal of Urology

Abstract

Our results support the view that neuroendocrine differentiation in prostatic adenocarcinomas is a prognostic factor for progressive disease under subsequent endocrine therapy. This prognosticator acts independently of tumor grade.

References

	Year	Citations
Regression Models and Life-Tables D. R. Cox Journal of the Royal Statistical Society Series B (Statistical Methodology) Regression ModelsReliability EngineeringConditional LikelihoodEngineeringLife Prediction	1972	38.8K
Terminal neuroendocrine differentiation of human prostate carcinoma cells in response to increased intracellular cyclic AMP. Yung‐Jue Bang, Farzaneh Pirnia, Wen‐Ning Fang, Proceedings of the National Academy of Sciences UrologyDevelopmental BiologySignal TransductionHormonal ReceptorIntracellular Cyclic Amp	1994	246
Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma Armen Aprikian, Carlos Cardon‐Cardo, William R. Fair, Cancer	1993	212
Ki67 LABELLING INDEX: AN INDEPENDENT PREDICTOR OF PROGRESSION IN PROSTATE CANCER TREATED BY RADICAL PROSTATECTOMY Lukas Bubendorf, Guido Sauter, Holger Moch, The Journal of Pathology	1996	203
Relation of endocrine‐paracrine cells to cell proliferation in normal, hyperplastic, and neoplastic human prostate Helmut Bonkhoff, Nicolas Wernert, G. Dhom, The Prostate Endocrine‐paracrine CellsUrologyNeoplastic Human ProstateCancer Cell BiologyPathology	1991	198
Small Cell Anaplastic Carcinoma of the Prostate: A Clinical, Pathological and Immunohistological Study of 27 Patients Joseph E. Oesterling, Claude G. Hauzeur, George M. Farrow The Journal of Urology UrologySurgical OncologyTumoral PathologyGenitourinary CancerMedicine	1992	191
The course of neuroendocrine differentiation in prostatic carcinomas Per‐Anders Abrahamsson, Sture Falkmer, K Fält, Pathology - Research and Practice UrologyProstatic CarcinomasBenign Prostatic HyperplasiaProstatic DiseaseNeuroendocrine Tumors	1989	190
Nuclear androgen receptors in the epithelium and stroma of human benign prostatic hypertrophic glands R. Lahtonen, N.J. Bolton, Reijo Vihko, The Prostate	1983	187
Elevated Plasma Chromogranin-A Concentrations in Prostatic Carcinoma Dov Kadmon, Timothy C. Thompson, Garrett R. Lynch, The Journal of Urology	1991	175
Neuroendocrine differentiation in prostatic carcinoma Paul A. di Sant'Agnese, Karen L. Jensen Human Pathology UrologyProstatic CarcinomaNeuroendocrine TumorsEndocrinologyMedicine	1987	156

Page 1